Found 0 matching trials
The Role of Secondary Bile Acids in Intestinal Inflammation PHASE2 The cause of Inflammatory bowel disease (IBD) is unknown, but intestinal ba...
Show More Location
Stanford University
Learn More & Join Trial
Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure PHASE2 Chronic liver diseases are often characterized by portal hypertension, a ma...
Show More Location
Hospital Clinic i Provincial de Barcelona
Learn More & Join Trial
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy PHASE4 Of those patients who participated in PEGASUS-D FAS clinical trial, patient...
Show More Learn More & Join Trial
Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment PHASE1 26 patients presenting a rhegmatogenous retinal detachment with more than 4...
Show More Location
University of Lausanne
Learn More & Join Trial
Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation N/A Patients with NAFLD indicated for ursodeoxycholic acid treatment ("by SPC: ...
Show More Status
Active Not Recruiting
Location
General University Hospital
Learn More & Join Trial
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia PHASE2 This pilot phase II trial studies how well ursodiol works in treating patie...
Show More Location
Southern Arizona Veterans Affairs Health Center
Learn More & Join Trial
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C PHASE3 This study is a 24-week multicenter, randomized, double-blind control trial...
Show More Location
Department of Gastroenterology, University of Tokyo
Learn More & Join Trial
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis PHASE1 Orthotopic liver transplantation (OLT) is currently the most effective meth...
Show More Location
the First Affiliated Hospital of Zhejiang University-IRB
Learn More & Join Trial
Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation PHASE3 The trial will compare the influence of treatment with ursodeoxycholic acid...
Show More Location
Hospital ClΓnico Universitario Virgen de la Arrixaca
Learn More & Join Trial
Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis NA This study aims to confirm whether the preventive use of ursodeoxycholic ac...
Show More Learn More & Join Trial